These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 22761267)
1. Managing the patient with newly diagnosed Parkinson disease. Singer C Cleve Clin J Med; 2012 Jul; 79 Suppl 2():S3-7. PubMed ID: 22761267 [TBL] [Abstract][Full Text] [Related]
2. Current and experimental treatments of Parkinson disease: A guide for neuroscientists. Oertel W; Schulz JB J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098 [TBL] [Abstract][Full Text] [Related]
3. Advances in the pharmacologic management of early Parkinson disease. Hauser RA; Zesiewicz TA Neurologist; 2007 May; 13(3):126-32. PubMed ID: 17495756 [TBL] [Abstract][Full Text] [Related]
4. Treatments for Parkinson disease--past achievements and current clinical needs. Poewe W Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317 [TBL] [Abstract][Full Text] [Related]
5. Early pharmacologic treatment in Parkinson's disease. Hauser RA Am J Manag Care; 2010 Mar; 16 Suppl Implications():S100-7. PubMed ID: 20297870 [TBL] [Abstract][Full Text] [Related]
6. Treatment of levodopa-induced motor complications. Stocchi F; Tagliati M; Olanow CW Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681 [TBL] [Abstract][Full Text] [Related]
7. An update on the treatment of Parkinson's disease. Jankovic J Mt Sinai J Med; 2006 Jul; 73(4):682-9. PubMed ID: 16878274 [TBL] [Abstract][Full Text] [Related]
8. Can we achieve neuroprotection with currently available anti-parkinsonian interventions? Olanow CW Neurology; 2009 Feb; 72(7 Suppl):S59-64. PubMed ID: 19221316 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease therapy: treatment of early and late disease. Jankovic J Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303 [TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. Fernandez HH; Chen JJ Pharmacotherapy; 2007 Dec; 27(12 Pt 2):174S-185S. PubMed ID: 18041937 [TBL] [Abstract][Full Text] [Related]
13. Optimizing pharmacotherapy: strategies to manage the wearing-off phenomenon. Tse W J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):12-7. PubMed ID: 17948614 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations. Bhidayasiri R; Ling H J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256 [TBL] [Abstract][Full Text] [Related]
15. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
16. Advanced strategies for treatment of Parkinson's disease: the role of early treatment. Jann MW Am J Manag Care; 2011 Oct; 17 Suppl 12():S315-21. PubMed ID: 22087552 [TBL] [Abstract][Full Text] [Related]
17. Milestones in Parkinson's disease therapeutics. Rascol O; Lozano A; Stern M; Poewe W Mov Disord; 2011 May; 26(6):1072-82. PubMed ID: 21626552 [TBL] [Abstract][Full Text] [Related]
18. Treatment of Parkinson's disease: levodopa as the first choice. Katzenschlager R; Lees AJ J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059 [TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Danisi F Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548 [TBL] [Abstract][Full Text] [Related]
20. Future treatments for Parkinson's disease: surfing the PD pipeline. Hauser RA Int J Neurosci; 2011; 121 Suppl 2():53-62. PubMed ID: 22035030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]